What’s Vulnerable › Vulnerabilities

CVE-2023-53734: dawa-pharma-1.0 - SQL Injection via Email Parameter

• Severity: high (CVSS 8.7 v4.0)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 0.5% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2025-12-04 · updated 2026-06-17
• Weakness: CWE-89

Description

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Affected products

• mayurik dawa-pharma: 1.0-2022

References

• https://github.com/nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/mayuri_k/2022/dawa-pharma-1.0-2022
• https://www.exploit-db.com/exploits/51818
• https://www.mayurik.com/source-code/P0349/best-pharmacy-billing-software-free-download
• https://www.nu11secur1ty.com/
• https://www.vulncheck.com/advisories/dawa-pharma-10-sql-injection-via-email-parameter

Get alerted when CVE-2023-53734 or the next vulnerability affects your stack